SCNI – scinai immunotherapeutics ltd. - american depositary shares (US:NASDAQ)
Stock Stats
News
Institutional Capital Returns as This Microcap Biotech Locks In Fresh Funding [Globe and Mail, The (Toronto, Canada)]
Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing
Scinai Immunotherapeutics (SCNI) had its "sell (e+)" rating reaffirmed by Weiss Ratings.
Scinai Completes Strategic Reorganization to Establish Dedicated CDMO Platform and Lean R&D Structure; Outlines 2026 Priorities
Scinai Reports Full-Year 2025 Results, with CDMO Revenues Doubling and Strategic Expansion Through Recipharm Collaboration [TheStreet.com]
Form 6-K Scinai Immunotherapeutic For: Apr 27
Form 20-F Scinai Immunotherapeutic For: Dec 31
Form 3 Scinai Immunotherapeutic For: Mar 18 Filed by: Mark Elad
Form 6-K Scinai Immunotherapeutic For: Mar 23
Form 6-K Scinai Immunotherapeutic For: Mar 19
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.